14
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Green Renal Replacement Therapy: Caring for the Environment

      Submit here before July 31, 2024

      About Blood Purification: 3.0 Impact Factor I 5.6 CiteScore I 0.83 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Increased Incidence of Malignancy in Chronic Renal Failure

      research-article
      , ,
      Nephron
      S. Karger AG
      Chronic renal failure, Malignancy incidence

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We have analysed the causes of death in a group of patients with chronic renal failure – serum creatinine more than 225 µmol/l (2.5 mg/100 ml) – and find that there is an increased incidence of malignancy when compared with the fatality rates for cancers in England and Wales (p < 0.0005). No patient in the series had received a transplant kidney or was therapeutically immunosuppressed for other reasons.

          Related collections

          Author and article information

          Journal
          NEF
          Nephron
          10.1159/issn.1660-8151
          Nephron
          S. Karger AG
          1660-8151
          2235-3186
          1977
          1977
          28 November 2008
          : 18
          : 3
          : 182-184
          Affiliations
          Renal Unit, Royal Infirmary, Hull
          Article
          180813 Nephron 1977;18:182–184
          10.1159/000180813
          859681
          5e9c1320-7634-488e-91c4-29f5b3d043bb
          © 1977 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 11 March 1976
          : 17 January 1976
          Page count
          Pages: 3
          Categories
          Original Paper

          Cardiovascular Medicine,Nephrology
          Malignancy incidence,Chronic renal failure
          Cardiovascular Medicine, Nephrology
          Malignancy incidence, Chronic renal failure

          Comments

          Comment on this article